MARKET

URGN

URGN

Urogen Pharma
NASDAQ
40.97
-1.53
-3.60%
After Hours: 40.97 0 0.00% 19:44 07/24 EDT
OPEN
42.52
PREV CLOSE
42.50
HIGH
42.89
LOW
40.78
VOLUME
421.33K
TURNOVER
--
52 WEEK HIGH
43.93
52 WEEK LOW
15.04
MARKET CAP
2.00B
P/E (TTM)
-14.9242
1D
5D
1M
3M
1Y
5Y
1D
Biotech stocks lead healthcare's overbought list as earnings picks up
Seeking Alpha · 2d ago
Analyst Sees Strong Zusduri Upside, Lifts UroGen Pharma Price Target from $35 to $50 with Buy Rating
TipRanks · 3d ago
UroGen Pharma Is Maintained at Buy by Guggenheim
Dow Jones · 3d ago
Guggenheim Maintains Buy on UroGen Pharma, Raises Price Target to $42
Benzinga · 3d ago
UroGen Pharma price target raised to $42 from $32 at Guggenheim
TipRanks · 4d ago
UroGen Pharma: Reimbursement Is Turning Zusduri Into A Workflow Moat
Seeking Alpha · 4d ago
Weekly Report: what happened at URGN last week (0713-0717)?
Weekly Report · 5d ago
Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027
Barchart · 07/17 09:15
More
About URGN
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Webull offers Urogen Pharma Ltd stock information, including NASDAQ: URGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, URGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading URGN stock methods without spending real money on the virtual paper trading platform.